A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
מצבים רפואיים
Paroxysmal Nocturnal Hemoglobinuria
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Hospital das Clinicas da FMRP USP, Ribeirão Preto, São Paulo, Brazil
Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil
CISSS-CA, Lévis, Quebec, Canada
Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli, Rome, Lazio, Italy
AOU Careggi, Florence, Tuscany, Italy
SC Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
In-Vivo Sp. z o.o., Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Seoul National University Hospital, Seoul, South Korea
Severance Hospital, Seoul, South Korea
Seoul St. Mary's Hospital - The Catholic University of Korea, Seoul, South Korea
Ewha Womans University Mokdong Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Hospital Universitario Basurto, Bilbao, Vizcaya, Spain
Institut Catala d'Oncologia, Barcelona, Spain
Hospital San Pedro de Alcantara, Cáceres, Spain
Hospital General JM Morales Meseguer, Murcia, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey (Türkiye)
Ege University, Izmir, Turkey (Türkiye)
מובילי המחקר
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals